Liesbeth Reneman

Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results.

The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain.

Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary report.

Ecstasy in the brain: a model for neuroimaging.

Validity of [123I]beta-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity.

Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach.

Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender.

Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats.

Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram.

The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance.

Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.

Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study.

Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.

A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users.

Cerebral impairment in chronic solvent-induced encephalopathy.

Neurotoxic effects of ecstasy on the thalamus.

Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users.

White matter fractional anisotropy correlates with speed of processing and motor speed in young childhood cancer survivors.

Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.

Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat.

Preliminary evidence of hippocampal damage in chronic users of ecstasy.

Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging.

Age-dependent effects of chronic fluoxetine treatment on the serotonergic system one week following treatment.

How the aging brain translates motivational incentive into action: The role of individual differences in striato-cortical white matter pathways.